Fundamental mechanisms of action of calcium antagonists in myocardial ischemia
- 30 January 1987
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 59 (3), B75-B83
- https://doi.org/10.1016/0002-9149(87)90086-5
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injuryJournal of Molecular and Cellular Cardiology, 1986
- The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogsAmerican Heart Journal, 1985
- Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatmentThe American Journal of Cardiology, 1985
- Protection by verapamil of globally ischemic rat hearts: Energy preservation, a partial explanationJournal of Molecular and Cellular Cardiology, 1985
- Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.Circulation, 1984
- Verapamil in acute myocardial infarctionEuropean Heart Journal, 1984
- Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.Circulation, 1984
- The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heartJournal of Molecular and Cellular Cardiology, 1980
- Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardiumThe American Journal of Cardiology, 1980
- Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusionJournal of Molecular and Cellular Cardiology, 1980